128 related articles for article (PubMed ID: 16538403)
1. Carcinoembryonic antigen, biomarker discovery, and trial design.
Yeatman TJ
Ann Surg Oncol; 2006 May; 13(5):600-1. PubMed ID: 16538403
[No Abstract] [Full Text] [Related]
2. Prognostic effect of perioperative change of serum carcinoembryonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer.
Park YA; Lee KY; Kim NK; Baik SH; Sohn SK; Cho CW
Ann Surg Oncol; 2006 May; 13(5):645-50. PubMed ID: 16538413
[TBL] [Abstract][Full Text] [Related]
3. Chemoradiation-induced changes in serum CEA and plasma TIMP-1 in patients with locally advanced rectal cancer.
Aldulaymi B; Christensen IJ; Sölétormos G; Jess P; Nielsen SE; Laurberg S; Brünner N; Nielsen HJ
Anticancer Res; 2010 Nov; 30(11):4755-9. PubMed ID: 21115936
[TBL] [Abstract][Full Text] [Related]
4. Dukes C2 colon cancer: what is appropriate follow-up?
Semin Oncol; 1995 Jun; 22(3):xix; discussion xix-xx passim. PubMed ID: 7777864
[No Abstract] [Full Text] [Related]
5. Carcinoembryonic antigen as a prognostic and monitoring test in colorectal carcinoma.
Chatterji A; Batabyal SK
Indian J Pathol Microbiol; 1987 Jan; 30(1):81-7. PubMed ID: 3679340
[No Abstract] [Full Text] [Related]
6. Carcinoembryonic antigen (CEA) measurement during follow-up for rectal carcinoma is useful even if normal levels exist before surgery. A retrospective study of CEA values in the TME trial.
Grossmann I; de Bock GH; Meershoek-Klein Kranenbarg WM; van de Velde CJ; Wiggers T
Eur J Surg Oncol; 2007 Mar; 33(2):183-7. PubMed ID: 17174516
[TBL] [Abstract][Full Text] [Related]
7. Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer.
Iizasa T; Suzuki M; Yoshida S; Motohashi S; Yasufuku K; Iyoda A; Shibuya K; Hiroshima K; Nakatani Y; Fujisawa T
Ann Thorac Surg; 2006 Jul; 82(1):254-60. PubMed ID: 16798225
[TBL] [Abstract][Full Text] [Related]
8. Doubling time of carcinoembryonic antigen is a significant prognostic factor after the surgical resection of locally recurrent rectal cancer.
Tanaka K; Noura S; Ohue M; Seki Y; Yamada T; Miyashiro I; Ohigashi H; Yano M; Ishikawa O; Murata K; Kameyama M; Imaoka S
Dig Surg; 2008; 25(4):319-24. PubMed ID: 18818499
[TBL] [Abstract][Full Text] [Related]
9. Carcinoembryonic antigen and patterns of recurrence after curative resection of the colorectal cancer.
Park JY; Lee KH
Hepatogastroenterology; 2007; 54(79):1966-9. PubMed ID: 18251140
[TBL] [Abstract][Full Text] [Related]
10. Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection.
Tang R; Yeh CY; Wang JY; Changchien CR; Chen JS; Hsieh LL
Ann Surg Oncol; 2009 Sep; 16(9):2516-23. PubMed ID: 19565285
[TBL] [Abstract][Full Text] [Related]
11. Combined measurement of hepatocyte growth factor and carcinoembryonic antigen as a prognostic marker for patients with dukes a and B colorectal cancer: results of a five-year study.
Miki C; Inoue Y; Hiro J; Ojima E; Araki T; Uchida K; Kusunoki M
Dis Colon Rectum; 2006 Nov; 49(11):1710-8. PubMed ID: 16990975
[TBL] [Abstract][Full Text] [Related]
12. [Carcinoembryonic antigen in cancer of the rectum and colon].
Prorokov VV; Tkacheva GA; Knysh VI; Kherkheulidze ZSh
Klin Med (Mosk); 1983 Jul; 61(7):86-9. PubMed ID: 6632761
[No Abstract] [Full Text] [Related]
13. [After-care of colorectal carcinoma--value of tumor markers].
Köhne CH; Benter T
Internist (Berl); 1997 Apr; 38(4):363-5. PubMed ID: 9213578
[No Abstract] [Full Text] [Related]
14. Multiple cancer foci in the colon of a man with operated rectum carcinoma.
Köklü S; Akbal E; Demirel AH; Gönültaş MA
Am Surg; 2010 Sep; 76(9):1021-2. PubMed ID: 20836356
[No Abstract] [Full Text] [Related]
15. Disseminated tumor cells in peripheral blood: a novel marker for therapy response in locally advanced rectal cancer patients undergoing preoperative chemoradiation.
Zitt M; Zitt M; Müller HM; Dinnewitzer AJ; Schwendinger V; Goebel G; De Vries A; Amberger A; Weiss H; Margreiter R; Ofner D; Oberwalder M
Dis Colon Rectum; 2006 Oct; 49(10):1484-91. PubMed ID: 17019657
[TBL] [Abstract][Full Text] [Related]
16. Predictors of recurrence in patients with T2 and early T3, N0 adenocarcinoma of the rectum treated by surgery alone.
Nissan A; Stojadinovic A; Shia J; Hoos A; Guillem JG; Klimstra D; Cohen AM; Minsky BD; Paty PB; Wong WD
J Clin Oncol; 2006 Sep; 24(25):4078-84. PubMed ID: 16943525
[TBL] [Abstract][Full Text] [Related]
17. [A case of high-dose rate interstitial brachytherapy for locally recurrent rectal cancer].
Noura S; Ohue M; Murata K; Kameyama M; Kishi K; Takachi K; Eguchi H; Yamada T; Miyashiro I; Yano M; Ohigashi H; Sasaki Y; Ishikawa O; Imaoka S
Gan To Kagaku Ryoho; 2006 Nov; 33(12):1801-3. PubMed ID: 17212112
[TBL] [Abstract][Full Text] [Related]
18. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
[TBL] [Abstract][Full Text] [Related]
19. Carcinoembryonic antigen as a predictor of pathologic response and a prognostic factor in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and surgery.
Park JW; Lim SB; Kim DY; Jung KH; Hong YS; Chang HJ; Choi HS; Jeong SY
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):810-7. PubMed ID: 19101093
[TBL] [Abstract][Full Text] [Related]
20. [Carcinoembryonic antigen, CEA, in colorectal cancer. An insensitive marker which may be excluded from follow-ups].
Wählby L
Lakartidningen; 1997 Apr; 94(18):1716-8. PubMed ID: 9182180
[No Abstract] [Full Text] [Related]
[Next] [New Search]